Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination

Silva Jr, Almir Ribeiro da; Villas-Boas, Lucy Santos; Tozetto-Mendoza, Tania Regina; Honorato, Layla; Paula, Anderson de; Witkin, Steven S.; Mendes-Correa, Maria Cassia.
Rev. Inst. Med. Trop. São Paulo (Online) ; 64: e19, 2022. tab
Artigo em Inglês | LILACS-Express | ID: biblio-1360801

Documentos relacionados

  1. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
  2. Multiplexed evaluation of immunity against SARS-CoV-2 variants using surface enhanced fluorescence from a nanostructured plasmonic chip.
  3. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
  4. Reduced neutralization against Delta, Gamma, Mu, and Omicron BA.1 variants of SARS-CoV-2 from previous non-Omicron infection.
  5. SARS-CoV-2 evolves to reduce but not abolish neutralizing action.
  6. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants.
  7. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
  8. Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.
  9. A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant.
  10. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.